These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2503555

  • 1. Mechanism of induction of endogenous tumor necrosis factor in ascites of ovarian cancer patients by OK-432, a streptococcal preparation.
    Mori H, Itoh N, Tamaya T.
    Immunopharmacol Immunotoxicol; 1989; 11(1):33-53. PubMed ID: 2503555
    [Abstract] [Full Text] [Related]

  • 2. Induction of endogenous tumor necrosis factor by OK-432 in ovarian cancer patients with ascites.
    Mori H, Itoh N, Yamada Y, Tamaya T.
    Biotherapy; 1989; 1(3):123-31. PubMed ID: 2518374
    [Abstract] [Full Text] [Related]

  • 3. [TNF induction in the serum and ascites of a gastric cancer patient treated with OK-432].
    Neda H, Watanabe N, Sone H, Yamauchi N, Niitsu Y, Urushizaki I.
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):593-7. PubMed ID: 3954382
    [Abstract] [Full Text] [Related]

  • 4. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
    Yamaguchi Y, Ohshita A, Kawabuchi Y, Hihara J, Miyahara E, Noma K, Toge T.
    Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
    [Abstract] [Full Text] [Related]

  • 5. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin.
    Satoh M, Inagawa H, Shimada Y, Soma G, Oshima H, Mizuno D.
    J Biol Response Mod; 1987 Oct; 6(5):512-24. PubMed ID: 2445926
    [Abstract] [Full Text] [Related]

  • 6. Induction of interferon-gamma and tumor necrosis factor in ascites of a patient with ovarian cancer by OK-432.
    Mori H, Itoh N, Shiraki S, Tamaya T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):497-8. PubMed ID: 3131464
    [No Abstract] [Full Text] [Related]

  • 7. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes].
    Katano M, Yamamoto H, Mizoguchi T, Hidaka K, Hisatsugu T, Torisu M.
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2464-8. PubMed ID: 3497612
    [Abstract] [Full Text] [Related]

  • 8. Production of tumor necrosis factor (TNF) by monocytes from cancer patients and healthy subjects induced by OK-432 in vitro, and its augmentation by human interferon gamma.
    Sekimoto M, Kokunai I, Shimano T, Kobayashi T, Takeda T, Haruna N, Yamamoto A, Mori T.
    J Clin Lab Immunol; 1988 Nov; 27(3):115-20. PubMed ID: 3150012
    [Abstract] [Full Text] [Related]

  • 9. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.
    Hayashi Y, Torisu M.
    Surgery; 1990 Jan; 107(1):74-84. PubMed ID: 2404351
    [Abstract] [Full Text] [Related]

  • 10. New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction.
    Katano M, Torisu M.
    Surgery; 1983 Mar; 93(3):365-73. PubMed ID: 6600854
    [Abstract] [Full Text] [Related]

  • 11. Essential requirement of toll-like receptor 4 expression on CD11c+ cells for locoregional immunotherapy of malignant ascites using a streptococcal preparation OK-432.
    Hironaka K, Yamaguchi Y, Okita R, Okawaki M, Nagamine I.
    Anticancer Res; 2006 Mar; 26(5B):3701-7. PubMed ID: 17094388
    [Abstract] [Full Text] [Related]

  • 12. [Management of malignant ascites by intraperitoneal injection of OK-432. Possible mechanism of the reduction of original tumor mass volume].
    Katano M, Mizoguchi T, Yamamoto H, Hisatsugu T, Torisu M.
    Nihon Geka Gakkai Zasshi; 1987 Dec; 88(12):1676-83. PubMed ID: 3447033
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic effect of OK-432 induced endogenous TNF on tumor bearing mice and cancer patients.
    Watanabe N, Niitsu Y, Yamauchi N, Neda H, Sone H, Urushizaki I, Yamamoto A, Nagamuta M, Sugawara Y.
    Immunopharmacol Immunotoxicol; 1988 Dec; 10(1):53-65. PubMed ID: 3361071
    [Abstract] [Full Text] [Related]

  • 14. [Effect of malignant ascitic fluids and OK-432 on the induction of LAK activity in peripheral blood mononuclear cells of gynecological cancer patients].
    Kanaoka Y, Umesaki N.
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jun; 43(6):611-8. PubMed ID: 1856521
    [Abstract] [Full Text] [Related]

  • 15. Ovarian cancer-induced immunosuppression: relationship to tumor necrosis factor-alpha (TNF-alpha) release from ovarian tissue.
    Hassan MI, Kassim SK, Saeda L, Laban M, Khalifa A.
    Anticancer Res; 1999 Jun; 19(6C):5657-62. PubMed ID: 10697636
    [Abstract] [Full Text] [Related]

  • 16. Induction of endogenous cytokines in ascites of patients with ovarian cancer by OK-432, a streptococcal preparation.
    Mori H, Itoh N, Yamada Y, Tamaya T.
    Asia Oceania J Obstet Gynaecol; 1989 Sep; 15(3):281-9. PubMed ID: 2512905
    [Abstract] [Full Text] [Related]

  • 17. [Transcatheter arterial embolization with hepatic arterial induction of endogenous TNF in hepatocellular carcinoma].
    Takekoshi H, Oyama R.
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2845-8. PubMed ID: 2476966
    [Abstract] [Full Text] [Related]

  • 18. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
    Wu S, Boyer CM, Whitaker RS, Berchuck A, Wiener JR, Weinberg JB, Bast RC.
    Cancer Res; 1993 Apr 15; 53(8):1939-44. PubMed ID: 8385577
    [Abstract] [Full Text] [Related]

  • 19. TNF induces endogenous TNF in vivo: the basis of EET therapy as a combination of rTNF together with endogenous TNF.
    Inagawa H, Oshima H, Soma G, Mizuno D.
    J Biol Response Mod; 1988 Dec 15; 7(6):596-607. PubMed ID: 3216223
    [Abstract] [Full Text] [Related]

  • 20. Induction of tumor necrosis factor by administration of OK-432 in cancer patients.
    Kokunai I, Shimano T, Sekimoto K, Takeda T, Kobayashi T, Yayoi E, Yamamoto A, Mori T.
    J Clin Lab Immunol; 1986 Dec 15; 21(4):169-71. PubMed ID: 3560194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.